Conclusion
Medicinal chemistry - Structure and activity of medicinal products
Article REF: P3280 V1
Conclusion
Medicinal chemistry - Structure and activity of medicinal products

Author : Serge KIRKIACHARIAN

Publication date: December 10, 2007, Review date: August 1, 2023 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

11. Conclusion

This study outlines the various stages involved in the discovery and development of a new active ingredient. Subsequently, and with a view to submitting a marketing authorization application for a drug (MA), the corresponding pharmaco-toxicological, clinical and pharmaceutical files must be supplied.

The pharmaceutical dossier includes a description of the preparation method, requiring the use of various industrial processes ranging from extraction to hemisynthesis or total synthesis. The choice of method generally depends on its cost price.

On the other hand, as long as the conformity of an active ingredient with the standards set by the pharmacopoeia or by the manufacturer has not been established, the active ingredient is not retained for pharmaceutical formulation, hence the importance of drug testing.

First,...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Ongoing reading
Conclusion

Article included in this offer

"Drugs and pharmaceuticals"

( 124 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details
Contact us